This policy brief, co-authored by the Global AMR R&D Hub and the European Union Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections (EU-JAMRAI), tackles the urgent and escalating threat of antibiotic resistance (AMR) jeopardising global health. With multi-drug resistant bacterial infections claiming over 33,000 lives in Europe alone in 2015, the situation demands immediate action. Despite this pressing need, antibiotic innovators struggle financially, hindering the development of new antibiotics. The policy brief advocates for the implementation of “pull” incentives to boost revenues for innovative antibiotics and delves into the perspectives of policymakers and AMR experts across European and global contexts.
Key points:
- The Global AMR R&D Hub and EU-JAMRAI performed in-depth interviews with policymakers and AMR experts from 13 countries across 4 continents to understand the barriers and facilitators for implementing incentives that promote antibiotic access and innovation.
- Three examples of European antibiotic pull mechanisms in progress are briefly explored (England, Germany and Sweden).
- The policy brief stresses the necessity for specific and detailed incentives to ensure predictable access to life-saving antibiotics, safeguarding public health against the challenges of antibiotic resistance.
